The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Prestrelski Steven since year 2005.
The trader's CIK number is 1744027.
At the time of the last reporting, Prestrelski Steven was the Chief Scientific Officer of Xeris Pharmaceuticals Inc .
(stock ticker symbol XERS).
See this page for all insider trading activities at Xeris Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-13||XERS||Xeris Pharmaceuticals Inc||Sale||10,000||5.50||54,990|
|2019-01-14||XERS||Xeris Pharmaceuticals Inc||Sale||7,700||17.20||132,463|
|2019-10-11||XERS||Xeris Pharmaceuticals Inc||Sale||10,000||7.97||79,750|
|2019-07-11||XERS||Xeris Pharmaceuticals Inc||Sale||10,000||12.37||123,690|
|2019-04-11||XERS||Xeris Pharmaceuticals Inc||Sale||10,000||9.56||95,650|
|2019-01-11||XERS||Xeris Pharmaceuticals Inc||Sale||2,300||.00||0|
|2018-12-26||XERS||Xeris Pharmaceuticals Inc||Sale||15,720||15.82||248,737|
|2018-12-24||XERS||Xeris Pharmaceuticals Inc||Option Ex||15,720||1.19||18,706|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prestrelski Steven (Chief Scientific Officer of Xeris Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.